Enhanced Data Verification Will Augment Empower's Integrated Technology Services and Goals

VANCOUVER BC / ACCESSWIRE / September 27, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce it has signed a Memorandum of Understanding with SoLVBL Solutions Inc. ("SoLVBL Solutions") to develop a cyber security program to detect cyber-attacks and provide data security to the diagnostic testing programs used by Empower.

SoLVBL Solutions is at the forefront of developing cybersecurity solutions and advanced unique capabilities for providing customers with capabilities to protect and verify incoming data against a range of cyber threats. The novel solution powered by SOLV's underlying technology, will incorporate dedicated data security mechanisms for Empower's diagnostic testing platform. As healthcare service providers face increased cybersecurity threats, the need for effective and resilient data security is paramount to maintain seamless healthcare services.

"We are excited to collaborate with SoLVBL Solutions, a company with broad know-how in data verification and cybersecurity. The collaboration agreement entered with Empower combines SoLVBL Solutions' data verification capabilities with Empower's experience and extensive expertise in the design, construction, operation, and maintenance of healthcare clinics and world-class diagnostic laboratories. With the increase in data collection, the demand to protect and verify data is unprecedented. We have seen such announcements come from both the Canadian and American governments. We feel this verification solution will allow us to continue to grow and meet the demands and needs of our patients and health care administrations. The collaboration aligns with our expansion and growth plans to become a global technological leader in the healthcare diagnostic sector." said Steven McAuley, CEO of Empower.

"We are extremely proud that SoLVBL Solutions' collaboration with Empower will yield a comprehensive cybersecurity solution for Empower's diagnostic testing platforms, answering a growing global cyber threat. We believe this will be the first of many such opportunities in the healthcare vertical, and one that we realized was needed and doable in our ongoing conversations with the Empower team. Together we realized the need for this level of data protection in this sector." said Raymond Pomroy, CEO of SoLVBL Solutions.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT SOLVBL SOLUTIONS INC.
SoLVBL Inc.™ takes a different approach to cybersecurity with its proprietary Q by SoLVBL™ protocol that quickly and cost-effectively establishes the authenticity of digital records at very high speed. We don't believe that any system is ‘un-hackable', no matter how secure it appears to be, and if a system can be hacked, the data within that system is subject to manipulation. Bad data leads to bad decisions. Our Mission: ‘To empower better, faster decisions by developing a universal standard for establishing digital record authenticity which is easy to adopt, cheap to use, offers cryptographic assurances, and will not bottleneck systems.'. The Company is currently pursuing the following verticals: chain of custody for digital evidence including NG-911; data used in the financial sector; medical applications; and critical IoT infrastructures.

ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:
Investors:
Steven McAuley CEO
s.mcauley@empowerclinics.com 604-789-2146

Investors:
Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
416-671-5617

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley's franchise model; launch of new healthcare centers and the occurrence thereof; that the Company can bring healthcare to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market- leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that Kai Medical Laboratory will successfully win any US Government RFP; that the MedX Health pilot program will be successful; that Empower will place the MedX Health teledermatology product in health centers in North America; that the Company's products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for Canadian clinics or Kai Medical Laboratory expansion inn 2Q 2021; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.